Specifically, increased TFR1 in MDS erythroblasts is expected to deliver more iron to erythroblast ferritin stores via increased PCBPs; more NCOA4 is expected to extract more iron from ferritin and more TFR2 to deliver more iron to mitochondria for Hb synthesis. The gene discussed is NCOA4; the disease is myelodysplastic syndrome.